Navigation Links
Gerresheimer Starts Process to Sell off its Business Segment of Technical Plastics
Date:7/31/2008

DUSSELDORF, Germany, August 1 /PRNewswire-FirstCall/ --

- Further Focus on Pharma & Life Science

Gerresheimer AG is to discontinue its business in technical plastic systems. The business segment, which primarily manufactures system components for suppliers to the automobile industry, is not part of the core business of pharma & life science. For this purpose the sale process has been started through an international invitation for bids.

"Through the sale of the technical plastics business we are, as previously announced, continuing our focus on the core business of pharma & life science, "says Dr. Axel Herberg, CEO of Gerresheimer AG.

In the segment of technical plastic systems, Gerresheimer employs 550 people at locations in Germany, the Czech Republic and Mexico as well as through joint ventures in Italy and Bulgaria, manufacturing system components for suppliers to the automobile industry. The main product focus is on vehicle electrics, powertrain and chassis as well as interior. Sales of around EUR 70m are expected for this segment in the financial year 2008.

Gerresheimer acquired the technical plastics business in 2007 as part of the Wilden Group. While the Wilden Group's business in medical plastic systems has today been firmly integrated in the Gerresheimer Group's portfolio, the technical plastics segment does not belong to Gerresheimer's core business in pharma & life science. Through the sale, portfolio rationalisation in the Plastic Systems Division will be completed.

In June this year, the Dusseldorf company already sold off its consumer healthcare business, which also did not fit in with its core business.

About Gerresheimer

Gerresheimer employs more than 10,300 people in 40 locations in Europe, America and Asia. In the financial year 2007, worldwide sales totalled EUR 958m. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery syst
'/>"/>

SOURCE Gerresheimer AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Gerresheimer Further Increases its Sales and Earnings Power
2. Gerresheimer Discontinues Marginal Operations
3. Moodys Raises Rating for Gerresheimer
4. Gerresheimer: Record Year in 2007 and Positive Outlook for 2008
5. 2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
6. Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board
7. Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
8. AMT Starts Collaboration With St. Jude Childrens Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
9. Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
10. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
11. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... OMICS Group’s 5th International conference and ... 2014 at Double Tree by Hilton Beijing, China is ... Analytical & Bioanalytical research methods only to facilitate improved ... occasion, Dr. Srinubabu Gedela, MD of OMICS Group Inc ... remarkable one in bringing a unique and international mix ...
(Date:7/10/2014)... POINT, Ind. , July 10, 2014 ... expanded its use of capnography for respiratory ... growing group of healthcare leaders in embracing ... measures how effectively patients are breathing and ... depression occurs. By measuring the amount of ...
(Date:7/10/2014)... Utah , July 10, 2014 /PRNewswire-iReach/ ... annotation and interpretation, today announced an agreement ... (NGS) analytics for Lineagen,s NextStep Dx ... of neurodevelopmental and neurological disorders, currently offers ... microarray (CMA) testing service used by healthcare ...
(Date:7/10/2014)... to the International Atomic Energy Agency (IAEA) the ... acquiring sufficient quantities of plutonium or highly enriched ... device. The IAEA also notes that most cases ... which can be challenging to detect with most ... appearing this week in the Journal of ...
Breaking Biology Technology:A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Sensitive detection method may help impede illicit nuclear trafficking 2
... April 26 ChromaDex Corporation (OTC Bulletin Board: ... and innovative ingredients to the dietary supplement, food, beverage ... pterostilbene(tero-STILL-bean). This exciting new product introduction is based on ... patent rights of pterostilbene from the University of ...
... ... 400umol/g delivers Market Leading Economies to Reduce Synthesis Costs and Increase Yields , ... Oceanside, CA (PRWEB) April ... Corporation, and the market leader in solid support for oligonucleotide synthesis, will be launching ...
... April 26 Transgenomic, Inc. (OTC Bulletin Board: ... the company as Technical Director for Laboratory Services.  Dr. Richardson will be ... will report to Craig Tuttle , Transgenomic,s president and chief executive ... Dr. Richardson has ...
Cached Biology Technology:ChromaDex Launches pTeroPure Pterostilbene 2ChromaDex Launches pTeroPure Pterostilbene 3ChromaDex Launches pTeroPure Pterostilbene 4ChromaDex Launches pTeroPure Pterostilbene 5Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Launch of NittoPhaseHL – High Loaded Solid Support for Oligonucleotide Synthesis 2Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Launch of NittoPhaseHL – High Loaded Solid Support for Oligonucleotide Synthesis 3Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Launch of NittoPhaseHL – High Loaded Solid Support for Oligonucleotide Synthesis 4Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services 2Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services 3
(Date:7/10/2014)... In Santa Fe, Albuquerque, and other major cities in ... watered with treated municipal wastewater rather than precious potable ... more than 40% of all golf courses receive treated ... courses. , Additionally, golf courses and homeowners alike ... nutrient in fertilizer is nitrate. A New Mexico State ...
(Date:7/10/2014)...  Aware, Inc. (NASDAQ: AWRE ), a ... on June 26, 2014 that its Board of Directors ... share, or approximately $40 million in total.  The Board ... a payment date of July 24, 2014.  The Company ... an ex-dividend date for this special cash dividend.  An ...
(Date:7/10/2014)... , July 2, 2014 It is a ... announce the appointment of the world-renowned Thoracic and Cardiovascular ... Directors. Dr. Ginsburg, with over 34 years ... Presbyterian Hospital and Good Samaritan Regional Medical Center. Dr. ... the late 1980,s and is considered an expert in ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2
... animals contain a large number of different bacteria. Humans are ... to a vast range of unicellular organisms, many of which ... no ill effects other than consuming some of the food ... Among them is Helicobacter pylori , which may play ...
... the ribosome represents the machinery necessary to assemble proteins, ... encoded in the genome,s DNA is first transcribed to ... ribosome where protein-assembly instructions are put in motion to ... recent years, it has been demonstrated that the ribosome ...
... Baltimore, MD September 18, 2013 Scientists at ... Vaccine Development are part of nationwide vaccine research aimed ... of avian (bird) influenza (flu) virus. The virus, called ... of mid-August, 135 confirmed human cases, including 44 deaths, ...
Cached Biology News:Getting rid of unwanted visitors 2Global analysis reveals new insights into the ribosome -- with important implications for disease 2Global analysis reveals new insights into the ribosome -- with important implications for disease 3Global analysis reveals new insights into the ribosome -- with important implications for disease 4University of Maryland researchers studying vaccine to prevent potential bird flu pandemic 2University of Maryland researchers studying vaccine to prevent potential bird flu pandemic 3
Monoclonal Antibody to GLP Immunogen: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)...
...
Homo sapiens MEP50 protein, mRNA...
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
Biology Products: